Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma

Cancer Genetics and Cytogenetics

Volumn 95, Issue 2, 1997, Pages 183-189

  Martinsson, Tommy ^a   Sjöberg, Rose Marie ^a   Hedborg, Fredrik ^b   Kogner, Per ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 17; GENE DELETION; GENE LOCATION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; GENES, NEUROFIBROMATOSIS 1; HOMOZYGOTE; HUMANS; NEUROBLASTOMA;

EID: 0342762036     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00259-2     Document Type: Article

References (41)

1. NIH Concensus Development Conference (1988): Neurofibromatosis conference statement. Arch Neurol 45:575-578.
2. Bader JL (1986): Neurofibromatosis and cancer. Ann NY Sci 486:57-65.
3. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J (1993): Neurofibromatosis type-1 and childhood cancer. Cancer 72:2746-2754.
4. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS (1990): Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181-186.
5. Shen MH, Harber PS, Upadhyaya M (1996): Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33:2-17.
6. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, Weiss R (1990): The neurofibromatosis type-1 gene encodes a protein related to gap. Cell 62:599-608.
7. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon RM, Innis MA, McCormick F (1990): The GAP-related domain of the neurofibromatosis type-1 gene product interacts with ras p21. Cell 63:843-849.
8. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J (1992): Aberrant regulation of ras proteins in malignant tumor cells from type 1 neurofibromatosis patients. Nature 356:713-715.
9. DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR (1992): Abnormal regulation of mammalian p21(ras) contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265-273.
10. Legius E, Marchuk DA, Collins FS, Glover TW (1993): Somatic deletion of the neurofibromatosis type-1 gene in neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-126.
11. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R (1992): Somatic mutations in the neurofibromatosis-1 gene in human tumors. Cell 69:275-281.
12. Andersen LB, Fountain JW, Gutmann DH, Tarle SA, Glover TW, Dracopoli NC, Housman DE, Collins FS (1993): Mutations in the neurofibromatosis-1 gene in sporadic malignant melanoma cell lines. Nat Genet 3:118-121.
13. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A (1993): Neurofibromatosis type-1 gene mutations in neuroblastoma. Nat Genet 3:62-66.
14. Johnson MR, Look AT, De Clue JE, Valentine MB, Lowy DR (1993): Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP-ras. Proc Natl Acad Sci USA 90:5539-5543.
15. Brodeur GM, Seeger RC, Barret A, Berthold F, Castleberry RP, D'Angio G, DeBernardi B, Evans A, Favot M, Freeman AI, Haase G, Hartmann O, Hayes FA, Helson L, Kemshead L, Lampeit F, Niane J, Ohkawa H, Philippe T, Pinkerton CR, Pritchard J, Sawada T, Siegel S, Smith EI, Tsuchida Y, Voute PA (1988): International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881.
16. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, Debernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA (1993): Revisions of the international criteria for neuroblastomas diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477.
17. Hedborg F, Lindgren PG, Johansson I, Kogner P, Kreuger A, Olsen L, Bekassy A, Samuelsson BO, Påhlman S (1992): N-myc gene amplification in neuroblastoma: A clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis. Med Fed Oncol 20:292-300.
18. Kogner P, Barbany G, Persson H, Soderhall S, Ahstrom L, Bjork O (1994): Expression of nerve growth factor receptor mRNAS and clinical response to retinoic acid in neuroblastoma. Prog Clin Biol Res 385:147-153.
19. Martinsson T, Sjöberg RM, Hedborg F, Kogner P (1995): Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55:5681-5686.
20. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G and Lathrop M (1992): A 2nd-generation linkage map of the human genome. Nature 359:794-801.
21. Lazaro C, Gaona A, Xu GF, Weiss R, Estivill X (1993): A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type-1 (NF1) gene. Hum Genet 92:429-430.
22. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994): The 1993-1994 genethon human genetic linkage map. Nat Genet 7:246-339.
23. Knudson Jr AG (1987): A two-mutation model for human cancer. Adv Vir Oncol 7:1-17.
24. Upadhyaya M, Shaw DJ, Harper PS (1994): Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 4:83-101.
25. Skuse GR, Kosciolek BA, Rowley PT (1992): Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17. Genes Chromosom Cancer 1:36-41.
26. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991): Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:245-255.
27. Look AT, Hayes FA, Shuster JJ, Douglas EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM (1991): Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma - A pediatric oncology group study. J Clin Oncol 9:581-591.
28. Savelyeva L, Corvi R, Schwab M (1994): Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
29. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F (1994): 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosom Cancer 10:103-114.
30. Caron H, van Sluis P, van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R (1994): Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
31. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H (1993): Coexpression of mRNA for trk protooncogenes and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044-2050.
32. Chang CL, Zhu XX, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, Hanash SM, Radany E (1994): nm23-H1 mutation in neuroblastoma. Nature 370:335-336.
33. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RL Jr, Shows TB, Mathew S, Murty VV, Chaganti RS (1993): Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23- 1 and NM23-2. Oncogene 8:497-502.
34. Laureys G, Speleman F, Opdenakker G, Benoit Y, Leroy J (1990): Constitutional translocation t(1:17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosom Cancer 2:252-254.
35. Laureys G, Speleman F, Versteeg R, van der Drift P, Chan A, Leroy J, Franke U, Opdenakker G, Van Roy N (1995): Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene 10:1087-1093.
36. Cawthon R, White R (1993): Molecular Genetics of Nervous System Tumours. AJ Levine, HH Schmidek, eds. Wiley Liss, New York, pp. 319-327.
37. Moley JF, Brother MB, Wells SA, Spengler BA, Biedler JL, Brodeur GM (1991): Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid tumors. Cancer Res 51:1596-1599.
38. Tanaka T, Slamon DJ, Shimada H, Shimoda H, Fujisawa T, Ida N, Seeger RC (1991): A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis; a retrospective study of 103 cases. Cancer 68:1296-1302.
39. Hagag N, Halegoua S, Viola M (1986): Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature 319:680-682.
40. Li BQ, Kaplan D, Kung HF, Kamata T (1992): Nerve growth factor stimulation of the ras-guanine nucleotide exchange factor and GAP activities. Science 256:1456-1459.
41. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF (1995): Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82:733-742.